The FDA should have more big news for Vertex only a few weeks later. It expects to announce an approval decision on ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

sending the drugmaker's stock price soaring while denting high-flying shares of vaccine companies and makers of other coronavirus therapies. Pfizer and its rivals, including U.S.-based Merck & Co ...

AstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time. Positive clinical trial results for Merck & Co's experimental ...

RedChip Companies will air interviews with Nova Minerals Limited and Soligenix Inc. on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, September 21, ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna.

BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...

RD received grants from Pfizer, Merck, MedImmune, and AstraZeneca ... royalties from AstraZeneca for the development of COVID-19 vaccines; consulting fees from Shionogi; is chair of the Joint ...

Merck paid $200 million to activate the programme, and another $250 million to license the melanoma vaccine. Fuelled with the windfall cash from its massively successful COVID-19 shot, Moderna has ...

The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...

Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...